Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q2 2023 Earnings
REGN
+0.34%
4
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
8.57
9.9
11.23
12.56
Details
Expected EPS
9.61
Actual EPS
10.09
Surprise EPS
0.48
Surprise Percent
+4.99%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 10.09 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login